Literature DB >> 21805942

Resource use and costs of end-of-Life/palliative care: Ontario adult cancer patients dying during 2002 and 2003.

Hugh Walker1, Mark Anderson, Farah Farahati, Doris Howell, S Lawrence Librach, Amna Husain, Jonathan Sussman, Raymond Viola, Rinku Sutradhar, Lisa Barbera.   

Abstract

The objective of this study is to estimate the direct medical cost of end-of-life and palliative (EOL/PAL) care for cancer patients during the last six months of their lives--or, during the period from diagnosis to death, if briefer--in 2002 and 2003, in Ontario, Canada. A linkage of cancer registry and administrative data is used to determine the costs of health care resources used during the EOL/PAL care period. Costs are analyzed by cancer diagnosis, location of death, and type of service. The total Ontario Ministry of Health-funded cost of EOL/PAL care for cancer patients is estimated to be about CAD$544 million per year, with an average per patient cost of about $25,000 in 2002-2003. Our results suggest that acute care consumes 75 percent of EOL/PAL funding and that only a small proportion of health care services used by EOL/PAL care cancer patients is likely to be formal palliative care.

Entities:  

Mesh:

Year:  2011        PMID: 21805942

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  16 in total

1.  Cost trajectories for cancer patients.

Authors:  W P Wodchis; E Arthurs; A I Khan; S Gandhi; M MacKinnon; J Sussman
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

2.  The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada.

Authors:  Christopher Hillis; Colin Vicente; Graeme Ball
Journal:  Pharmacoeconomics       Date:  2022-07-18       Impact factor: 4.558

Review 3.  End-of-Life Care Interventions: An Economic Analysis.

Authors:  B Pham; M Krahn
Journal:  Ont Health Technol Assess Ser       Date:  2014-12-01

4.  Population-based home care services in breast cancer: utilization and costs.

Authors:  N Mittmann; P K Isogai; R Saskin; N Liu; J M Porter; M C Cheung; N B Leighl; J S Hoch; M E Trudeau; W K Evans; K N Dainty; C C Earle
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

5.  Utilization and costs of home care for patients with colorectal cancer: a population-based study.

Authors:  Nicole Mittmann; Ning Liu; Joan Porter; Soo Jin Seung; Pierre K Isogai; Refik Saskin; Matthew C Cheung; Natasha B Leighl; Jeffrey S Hoch; Maureen Trudeau; William K Evans; Katie N Dainty; Craig C Earle
Journal:  CMAJ Open       Date:  2014-02-04

6.  Economic evaluation of adjuvant trastuzumab emtansine in patients with HER2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab-based treatment in Canada.

Authors:  T Younis; A Lee; M E Coombes; N Bouganim; D Becker; C Revil; G S Jhuti
Journal:  Curr Oncol       Date:  2020-12-01       Impact factor: 3.677

7.  The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada.

Authors:  Peter Tanuseputro; Walter P Wodchis; Rob Fowler; Peter Walker; Yu Qing Bai; Sue E Bronskill; Douglas Manuel
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

8.  Impact of aggressive management and palliative care on cancer costs in the final month of life.

Authors:  Matthew C Cheung; Craig C Earle; Jagadish Rangrej; Thi H Ho; Ning Liu; Lisa Barbera; Refik Saskin; Joan Porter; Soo Jin Seung; Nicole Mittmann
Journal:  Cancer       Date:  2015-05-29       Impact factor: 6.860

9.  Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute.

Authors:  Younak Choi; Bhumsuk Keam; Tae Min Kim; Se-Hoon Lee; Dong-Wan Kim; Dae Seog Heo
Journal:  Cancer Res Treat       Date:  2015-02-16       Impact factor: 4.679

10.  Testing an unconventional mortality information source in the canton of Geneva Switzerland.

Authors:  Emmanuel Kabengele Mpinga; Véronique Delley; Emilien Jeannot; Joachim Cohen; Philippe Chastonay; Donna M Wilson
Journal:  Glob J Health Sci       Date:  2013-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.